Plasma calprotectin and its association with cardiovascular disease manifestations, obesity and the metabolic syndrome in type 2 diabetes mellitus patients

BACKGROUND: Plasma calprotectin is a potential biomarker of cardiovascular disease (CVD), insulin resistance (IR), and obesity. We examined the relationship between plasma calprotectin concentrations, CVD manifestations and the metabolic syndrome (MetS) in patients with type 2 diabetes mellitus (T2D...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:BMC Cardiovasc Disord
Main Authors: Pedersen, Lise, Nybo, Mads, Poulsen, Mikael Kjær, Henriksen, Jan Erik, Dahl, Jordi, Rasmussen, Lars Melholt
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2014
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4289556/
https://ncbi.nlm.nih.gov/pubmed/25527236
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2261-14-196
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares